Pharmaceutical News and Articles

Beta Blockers Unnecessary for Folks Without Heart Failure; May Be Linked to Depression

Beta blockers are go-to meds for many people who ve survived a heart attack. However, new Swedish research has found that they might not be needed for heart att

U.S. Alcohol Intake Rose During Pandemic, and for Years After

Even as the pressures of the pandemic began to ebb, Americans growing dependence on alcohol did not, a troubling new study shows. inched even further up in 2021

Kids Still Find It Easy to Buy Flavored Vapes Online

If you think that federal restrictions on the sale of tobacco products make it nearly impossible for your teen to buy vapes online, new research suggests you re

Grandparents & Grandkids: Poll Shows Them Helping Each Other

Grandchildren are a true blessing for seniors, helping them avoid loneliness and keeping them on their toes, a new poll reports. Overall, 72 of people with gran

Vitamin D Supplements Could Help Lower Blood Pressure in Obese People

Vitamin D supplements might lower blood pressure in seniors who are obese, reducing their heart health risk, a new study says. But taking more than the recommen

Palleon Pharmaceuticals Presents Results from the Phase 1/2 GLIMMER-01 Trial of E-602 in Combination with Cemiplimab in Patients with Solid Tumors at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

WALTHAM, MA, November 8, 2024 Palleon Pharmaceuticals, a clinical-stage company pioneering glyco-immunology drug development to treat autoimmune diseases and ca

AbbVie Provides Update on Phase 2 Results for Emraclidine in Schizophrenia

AbbVie (NYSE ABBV) today announced that its two Phase 2 EMPOWER trials investigating emraclidine as a once-daily, oral monotherapy treatment for adults with sch

Nipocalimab is the First and Only Investigational Therapy Granted U.S. FDA Breakthrough Therapy Designation for the Treatment of Adults Living with Moderate-to-Severe Sjögren’s Disease

Spring House, PA (November 11, 2024) Johnson Johnson (NYSE JNJ) today announced that the U.S. Food and Drug Administration (FDA) has granted nipocalimab Breakth

Satsuma Pharmaceuticals and SNBL Resubmits the New Drug Application for STS101 (Dihydroergotamine Nasal Powder) for the Acute Treatment of Migraine With or Without Aura

Unicycive Therapeutics Announces U.S. FDA Acceptance of the New Drug Application (NDA) for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis